
Waterland backed Medhold sold to Sonic Healthcare
Waterland Private Equity has divested its stake in Belgian laboratory business Medhold Group to Australian-based Sonic Healthcare who has fully acquired the business.
The purchase price for Medhold is based on an enterprise value of €232m and represents an EBITDA multiple of approximately 8.4x before synergies.
Waterland invested in Medhold in December 2007 as part of an expansion deal, acquiring a 50% stake in the company.
Founded in 1980 the Medhold Group employs over 300 staff and operates from a new, purpose-built, state-of-the-art reference laboratory in Antwerp.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater